107. Savignano C., Rinaldi C., De Angelis V. Pregnancy associated thrombotic thrombocytopenic purpura: Practical issues for patient management. Transfus Apher Sci. 2015;53(3):262–8. DOI:10.1016/J.TRANSCI.2015.11.005.
108. Fakhouri F., Scully M., Provot F., et al. Management of thrombotic microangiopathy in pregnancy and postpartum: Report from an international working group. Blood. 2020;136(19):2103–17. DOI:10.1182/BLOOD.2020005221.
109. Gangaraju R., Rodgers G.M. Upshaw-Schulman syndrome and pregnancy: successful management with plasma infusions. Ann Hematol. 2016;95(10):1745–6. DOI:10.1007/S00277-016-2755-2.
110. Ferrari B., Peyvandi F. How I treat thrombotic thrombocytopenic purpura in pregnancy. Blood. 2020;136(19):2125–32. DOI:10.1182/BLOOD.2019000962.
111. Coppo P., Schwarzinger M., Buffet M., et al. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: The French TMA reference center experience. PLoS One. 2010;5(4):e1028. DOI:10.1371/journal.pone.0010208.
112. Bendapudi P.K., Hurwitz S., Fry A., et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017;4(4):e157–64. DOI:10.1016/S2352-3026(17)30026-1.